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BACKGROUND
Like all other stem cells, the bone marrow-derived mesenchymal stem cells are the multipotential cells keeping their self-renewal 
properties during sequential cell divisions. These cells can be targeted for differentiating into various types of the cells such as neurons, 
chondrocytes and osteocytes used for the cell transplantation purposes.  Recent studies show that about 99% of these transplanted cells 
are destroyed by oxidative stresses. The study described here was designed to increase the BM-MSCs’ viability against the oxidative 
stresses using Deferoxamine (DFO) as an iron chelator which has been already shown that protects the cells by upregulating a cytopro-
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METHODS
BM-MSCs were isolated from the rat femur and cultured in DMEM-LG medium and 20% FBS. Using MTT assay, viability of the 
H2O2 and DFO-exposed BM-MSCs at different doses was evaluated, separately. Then, BM-MSCs pretreated with DFO (for 48h) were 
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cells by qRT-PCR methods. 
RESULTS
IC50 dose for H2O2 treatment of BM-MScs was 0.55 mM. We also showed that the maximum effective dose of DFO was about 5 μM. 
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CONCLUSTION
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against oxidative stress induced by H2O2 and improves their viability. 
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